VX1 vs QFR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Volta Medical
VS
by Medis Medical Imaging

AI Verdict

Tool A (VX1) is designed for real-time guidance during atrial fibrillation and atrial tachycardia ablation procedures by analyzing electrograms. In contrast, Tool B (QFR) focuses on the analysis of X-ray angiographic images to assess coronary vessel lesions and quantify blood flow. While both are FDA-cleared cardiology AI tools, they address distinct clinical problems within different sub-specialties.

Choose VX1 if…

Choose VX1 if your primary need is real-time, AI-guided assistance during atrial fibrillation or atrial tachycardia ablation procedures. This tool is ideal for electrophysiologists seeking to identify dispersed electrograms and enhance procedural standardization and outcomes.

View VX1 →

Choose QFR if…

Choose QFR if you require AI-powered analysis of X-ray angiographic images to assess coronary vessel lesions. This software is best suited for cardiologists needing quantitative flow ratio (QFR) assessment and 3D reconstruction to determine the functional significance of coronary artery disease.

View QFR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature VX1 QFR
Pricing Contact for pricing Unknown
Deployment Software integrated with existing electrophysiology (EP) lab mapping and recording systems. On-premise (integrates into cath lab environment)
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1

Tool A (VX1) is described as having a 'Simple User Interface for Real-Time Regions of Interest Identification' and provides 'real-time visual and sound cues' to guide cardiologists during procedures. Its compatibility with most existing EP systems and the offering of automatic annotation in newer versions suggest a highly intuitive and integrated workflow.

Clinical Value

QFR

Tool B (QFR) has demonstrated significant clinical impact, with one study showing a 35% reduction in major adverse cardiac events (MACE) for QFR-guided PCI compared to standard angiography-guided PCI. It is also included in the European Society of Cardiology (ESC) guidelines as a Class I-recommended approach for guiding revascularization. While Tool A (VX1) assists in standardizing ablation procedures, its FDA clearance explicitly states that its clinical significance for patient outcomes has not yet been established by clinical investigations.

Pricing & Value

Tie

Both Tool A (VX1) and Tool B (QFR) require direct contact for pricing information, and neither provides transparent pricing details or specific return on investment (ROI) studies. Without this crucial information, it is impossible to conduct a meaningful comparison of their pricing and overall value proposition.

Enterprise Readiness

Tie

Both tools are FDA-cleared medical devices designed for integration into existing clinical environments (EP labs for VX1, cath labs for QFR), indicating a high level of readiness for hospital deployment. While explicit HIPAA compliance or BAA statements were not found for either in the provided data or search results, such compliance is generally expected for FDA-cleared medical devices handling patient data.

Innovation

VX1

Tool A (VX1) holds the distinction of being the 'first FDA clearance for an AI based tool in interventional cardiac electrophysiology,' offering real-time, AI-guided decision support during complex ablation procedures. Its ability to provide dynamic, intra-procedural guidance with visual and sound cues represents a significant innovation in live intervention.

Support & Docs

VX1

Tool A (VX1) explicitly provides access to a 'User Manual' and 'Brochure' on its website, along with mentions of 'Technical Documentation' and 'PDF Catalogs.' For Tool B (QFR), relevant support and documentation information for the medical device could not be found through web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature VX1 QFR
Tool Name VX1 QFR
Company Volta Medical QFR Solutions bv
Primary Medical Specialty Cardiology Cardiology
Core AI Application Real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. Visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments.
Target Procedure/Assessment Atrial fibrillation and atrial tachycardia ablation procedures. Lesion assessment in coronary vessel segments.
Key Feature Example AI-guided real-time identification of dispersed electrograms (EGMs) Quantitative Flow Ratio (QFR) assessment for functional significance

Videos

Demos, reviews, and walkthroughs featuring VX1 and QFR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. QFR is an FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment.
VX1 is specifically designed to assist cardiac electrophysiologists during AFib and atrial tachycardia ablation procedures. QFR is intended for cardiologists involved in assessing coronary lesions, utilizing X-ray angiographic images, which is typically relevant for interventional cardiology or diagnostic imaging.
VX1 is software integrated with existing electrophysiology (EP) lab mapping and recording systems, and is compatible with most EP recording, 3D navigation systems, and mapping catheters. QFR is deployed on-premise and integrates with cath lab systems, with the capability to receive DICOM images from enterprise cath lab systems and PACS.
VX1 analyzes 3D anatomical and electrical maps of human atria to identify dispersed electrograms and provides cycle length estimation from electrograms. QFR visualizes and analyzes X-ray angiographic images of coronary vessel segments, performing calculations and 3D reconstruction of coronary vessel models.
VX1 offers AI-guided real-time identification of dispersed electrograms, designed to reduce inter-operator variability and standardize outcomes. QFR features include automatic detection and editing of vessel contours, 3D reconstruction of coronary vessel models, quantitative flow ratio (QFR) assessment for functional significance, and AI-enabled end-diastolic frame selection.
AI Tool Finder
AI-powered search. Results may not be comprehensive.